Is Vitamin B12 Important in Multiple Sclerosis? MStranslate December 20, 2023 Fingolimod, Research, Vitamin B12 2 Comments Research Summary: FTY720 requires vitamin B12-TCN2-CD320 signaling in astrocytes to reduce disease in an animal model of multiple sclerosis The treatment of multiple sclerosis has improved greatly over the...
MOMENTUM Phase II Trial Results MStranslate August 22, 2016 Clinical Trials, Fingolimod, Research The background Fingolimod was approved in 2010 and became the first oral drug for the treatment of relapsing-remitting MS (RRMS). It has proven to be beneficial for many people with MS and works by...
Rituximab vs Fingolimod in JCV+ Individuals MStranslate April 5, 2016 Fingolimod, Natalizumab, Research, Rituximab Research Summary: Rituximab versus fingolimod after natalizumab in multiple sclerosis patients The background Whilst natalizumab has emerged as a potent treatment for multiple sclerosis (MS), it is also...
Fingolimod After Natalizumab & Short-term Relapse Risk MStranslate March 27, 2014 Fingolimod, Natalizumab, Research, Treatments Dr Vilija Jokubaitis et al Natalizumab (Tysabri) is an antibody used for the treatment of multiple sclerosis (MS). It is currently the strongest drug available for the treatment of MS, however, it has also...
